Document Type
Blog Post
Publication Date
1-18-2022
Digital USD Citation
Serbin, Kenneth P. PhD, "After setback, Roche to run new clinical trial with Huntington’s disease gene silencing drug" (2022). At Risk for Huntington's Disease. 341.
https://digital.sandiego.edu/huntingtons/341
COinS